Results 191 to 200 of about 1,619,548 (347)
Perspective: Raman spectroscopy for detection and management of diseases affecting the nervous system. [PDF]
Robertson JL, Sayed Issa A, Senger RS.
europepmc +1 more source
Magnetic Resonance Imaging in Diseases of the Nervous System [PDF]
Timothy C. Cox, John Bingham
openalex +1 more source
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak +4 more
wiley +1 more source
A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System. [PDF]
Bellizzi A +3 more
europepmc +1 more source
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec +6 more
wiley +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Diseases of the nERVous system: retrotransposon activity in neurodegenerative disease. [PDF]
Tam OH, Ostrow LW, Gale Hammell M.
europepmc +1 more source

